{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:00:57Z","timestamp":1784948457156,"version":"3.55.0"},"reference-count":47,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"Anderson Cancer Center"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2020,7,2]]},"DOI":"10.1080\/14737140.2020.1776120","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T06:51:32Z","timestamp":1590648692000},"page":"543-550","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm"],"prefix":"10.1080","volume":"20","author":[{"given":"Sophia S.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, The University of Texas School of Health Sciences at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"McCue","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Pemmaraju","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815105"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06458.x"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.072645"},{"key":"cit0005","unstructured":"Treatment advances in blastic plasmacytoid dendritic cell neoplasm \u2013 hematology & oncology. [cited 2020 Mar 3]. https:\/\/www.hematologyandoncology.net, https:\/\/www.hematologyandoncology.net\/archives\/april-2019\/treatment-advances-in-blastic-plasmacytoid-dendritic-cell-neoplasm\/."},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14146"},{"key":"cit0007","volume-title":"World health organization classification of tumours","author":"Swerdlow SH","year":"2017"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-337501"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.03.022"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2329"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000569"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2015.27.6.727"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.903059"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000647"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07679.x"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000156"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.01.013"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0154-5"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.101"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22831"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08556.x"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.359"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0262-0"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1512970"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12523"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2671"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4146"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050595"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1177\/2040620719874733"},{"key":"cit0030","first-page":"3942","volume":"122","author":"Fanny D","year":"2013","journal-title":"Blood"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.23.12551"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-2-4"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401903"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.111740"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-566737"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1309\/GJWNPD8HU5MAJ837"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7010006"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1662297"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701799035"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1172\/JCI128571"},{"key":"cit0041","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood.V130.Suppl_1.797.797","volume":"130","author":"Stephansky J","year":"2017","journal-title":"Blood"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.026179"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2017.1370"},{"key":"cit0044","unstructured":"Sun W, Liu H, Young K, et al. First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases. PubMed - NCBI. [cited 2019 Nov 17]. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29720227."},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.64"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.202093"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.10.002"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2020.1776120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T14:09:56Z","timestamp":1620482996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2020.1776120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,2]]}},"alternative-id":["10.1080\/14737140.2020.1776120"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2020.1776120","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}